Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Circulating Nucleic Acids and Circulating Rare Cells: Liquid Biopsy for Early Cancer Detection

Circulating Nucleic Acids and Circulating Rare Cells: Liquid Biopsy for Early Cancer Detection



Keynote Speakers


J. Carl Barrett
Vice President, Translational Sciences Oncology, AstraZeneca


George Calin
Professor and The Alan M. Gewirtz Leukemia & Lymphoma Society Scholar, University of Texas MD Anderson Cancer Center


Bob Carter
Professor and Chief of Neurosurgery, Massachusetts General Hospital, Harvard Medical School


Daniel Chiu
A. Bruce Montgomery Professor of Chemistry, University of Washington


Anindya Dutta
Harry F. Byrd Professor and Chair of Biochemistry and Molecular Genetics and Professor of Pathology, University of Virginia School of Medicine


Jennifer Jones
NIH Stadtman Investigator, Head of Transnational Nanobiology, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute


Walter Koch
Vice President, Roche Molecular Systems


Lucia Languino
Professor of Cancer Biology, Thomas Jefferson University


Cheng-Ho Jimmy Lin
Chief Scientific Officer, Oncology, Natera


Y. Peng Loh
Chief and Senior Investigator, Section on Cellular Neurobiology, Eunice Kennedy Shriver National Institute of Child health and Human Development, National Institutes of Health (NIH)


Jan Lötvall
Professor Krefting Research Centre, University of Gothenburg, Chief Scientist, Codiak BioSciences; Founding President of ISEV


Mike Makrigiorgos
Professor of Radiation Oncology, Dana Farber Cancer Institute and Harvard Medical School


Balaji Panchapakesan
Professor, Department of Mechanical Engineering, Worcester Polytechnic Institute (WPI)


Steven Pirie-Shepherd
Director, Pfizer


Peter Quesenberry
Professor of Medicine, The Warren Alpert Medical School of Brown University


Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-scale System for Precision Medicine, The University of Kansas, Adjunct Professor, Ulsan National Institute of Science & Technology


Shannon Stott
Assistant Professor, Massachusetts General Hospital & Harvard Medical School


David Wong
Felix and Mildred Yip Endowed Chair in Dentistry; Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles

Overview

Select Biosciences Fifth Annual Circulating Biomarkers World Congress 2018 brings together the most up-to-date technologies and advances in this expanding and evolving field.  Our coverage in this conference track focuses on the various classes of circulating nucleic acid biomarkers:
  • Circulating Nucleic Acids: Circulating Cell-Free DNA (cfDNA)
  • Circulating RNAs such as microRNAs in Biofluids
This conference features speakers from academia as well as industry addressing the following topic areas:
  • Technologies for Isolation and Characterization from Various Biofluids
  • Role in Cancer and Various Other Disease Classes (such as Cardiovascular Disease, CNS Disease and Beyond)
  • Biomarker Potential for Diagnostics Development
Registered delegates receive access to the co-located concurrent conference tracks, the co-located exhibit hall featuring companies providing tools and technologies address the circulating biomarkers field, as well as round-table discussions facilitating networking in specific topic areas.


Agenda Topics

  • Circulating microRNAs, Other Classes of Circulating RNAs from Biofluids
  • Circulating Nucleic Acids and Circulating Tumor Cells (CTCs): Circulating Biomarkers for Liquid Biopsy Development
  • Circulating Nucleic Acids in Various Disease Classes
    • Cancer
    • Cardiovascular Disease
    • CNS and Neurodegenerative Diseases
    • Pregnancy and Reproductive Health
  • Circulating-Free DNA/Cell-Free DNA (cfDNA)
  • Liquid Biopsies for Early Cancer Detection

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Distinguished Faculty

Chung- Er Huang, Assistant Professor, National Chiao Tung University; Managing Director, CytoAurora Biotechnologies, Inc.
Allison Welsh, Associate Director, Liquid Biopsy Development, Foundation Medicine
Abhijit Patel, Associate Professor, Yale University School of Medicine
Michael Graner, Associate Professor, Dept of Neurosurgery, University of Colorado Anschutz School of Medicine
Frank Slack, Director, Institute for RNA Medicine, Beth Israel Deaconess Medical Center Cancer Center/Harvard Medical School
Taylor Jensen, Director, Research and Development, Sequenom (a LabCorp Company)
Brian Dougherty, Executive Director, Translational Genomics, Oncology IMED, AstraZeneca R&D
John Castle, Executive Director, Vaccine Research and Translational Medicine, Agenus Switzerland Inc.
Dana Al Sulaiman, Postgraduate Researcher, Imperial College London
Cha-Mei Tang, President and CEO, Creatv MicroTech
Peter Benn, Professor Emeritus, Department of Genetics and Genome Sciences, University of Connecticut Health Center
Qing Kang, Senior Scientist, Translational Medicine, Syros Pharmaceuticals, Inc.
Ryan Dittamore, Vice President, Translational Research and Clinical Affairs, Epic Sciences


Corporate SponsorsWeb SponsorsOffical Journal PartnerNetworking
Drug Discovery WorldU-Networks